未登录

S

Shashi N. Kapadia

weill cornell medical college

H指数:21

被引数:1,461

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Integrated infectious disease and substance use disorder treatment for severe injection-related infections: protocol for the randomized controlled HI-SIRI trial

针对严重注射相关感染的整合传染病与物质使用障碍治疗方案：HI-SIRI随机对照试验方案

Addiction Science & Clinical Practice

IF3.2

2026-02-210

OAAI

Improving hospital-based care for patients with injection-drug related infections: provider perspectives

改善与注射药物相关感染患者的院内护理：提供者视角

Addiction Science & Clinical Practice

IF3.2

2026-02-090

OAAI

Identifying Varying Influences on Eliminating Hepatitis C Across Medical Specialties

JOURNAL OF VIRAL HEPATITIS

IF2.3

2025-11-010

PRE

State Laws Banning Prior Authorization For Medications For Opioid Use Disorder Increased Substantially, 2015-23

IF8.1

2025-11-010

PRE

Developing and validating measures of take-home methadone with administrative data

JOURNAL OF SUBSTANCE USE & ADDICTION TREATMENT

IF1.9

2025-10-010

OAAI

Providers' Perspectives on Implementation of Low-threshold HCV Treatment in New York State: A Qualitative Study

提供者对纽约州低阈值HCV治疗实施的观点：一项定性研究

OPEN FORUM INFECTIOUS DISEASES

IF3.8

2025-03-260

OA

Budget Impact Tool for Integrating Buprenorphine and Outpatient Parenteral Antibiotic Therapy for People who Inject Drugs Hospitalized With Severe Infections

DRUG AND ALCOHOL DEPENDENCE

IF3.6

2025-02-010

PRE

PICC Your Poison: Resident Beliefs and Attitudes Regarding Discharge Parenteral Antibiotics for Patients Who Inject Drugs

OPEN FORUM INFECTIOUS DISEASES

IF3.8

2024-06-270

OAAI

The State of Hepatitis C Elimination from the Front Lines: A Qualitative Study of Provider-Perceived Gaps to Treatment Initiation

JOURNAL OF GENERAL INTERNAL MEDICINE

IF4.2

2024-05-230

PRE

Association between claims-based setting of diagnosis and treatment initiation among Medicare patients with hepatitis C

HEALTH SERVICES RESEARCH

IF3.2

2024-05-210

OA

The Urgent Need to Implement Point-of-Care RNA Testing for Hepatitis C Virus to Support Elimination

CLINICAL INFECTIOUS DISEASES

IF7.3

2023-08-273

OA

Treated like a Human Being: perspectives of people who inject drugs attending low-threshold HCV treatment at a syringe service program in New York City

像人一样对待: 在纽约市的注射器服务计划中接受低阈值HCV治疗的注射吸毒者的观点

HARM REDUCTION JOURNAL

IF4

2023-07-279

OAAI

The effects of COVID-19 on New York State's Drug User Health Hubs and syringe service programs: a qualitative study

HARM REDUCTION JOURNAL

IF4

2023-02-027

OAAI

Specialist and Primary Care Treatment of Hepatitis C Infections in US Medicaid in 2018

JOURNAL OF GENERAL INTERNAL MEDICINE

IF4.2

2022-11-024

OA

Availability of and Obstacles to Providing COVID-19 Vaccinations at Syringe Services Programs in the United States, 2021

PUBLIC HEALTH REPORTS

IF2.5

2022-09-166

OAAI

Medicaid Hepatitis C Virus Treatment Policies: Impact on Testing and Treatment in the Commercially Insured

AMERICAN JOURNAL OF PREVENTIVE MEDICINE

IF4.5

2022-09-014

PRE

Impact of prenatal substance use policies on commercially insured pregnant females with opioid use disorder

产前药物使用政策对商业保险的阿片类药物使用障碍孕妇的影响

JOURNAL OF SUBSTANCE ABUSE TREATMENT

IF4

2022-09-0124

OAAI

Syringe Service Program Perspectives on Barriers, Readiness, and Programmatic Needs to Support Rollout of the COVID-19 Vaccine

JOURNAL OF ADDICTION MEDICINE

IF3.2

2022-08-025

OAAI

Hepatitis C virus risk among young people who inject drugs

FRONTIERS IN PUBLIC HEALTH

IF3.4

2022-07-2912

OAAI

Responding to a surge in overdose deaths: perspectives from US syringe services programs

HARM REDUCTION JOURNAL

IF4

2022-07-1918

OA